Dalin Rifat

922 total citations
15 papers, 640 citations indexed

About

Dalin Rifat is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Dalin Rifat has authored 15 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Epidemiology and 6 papers in Molecular Biology. Recurrent topics in Dalin Rifat's work include Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (11 papers) and Bacterial Genetics and Biotechnology (4 papers). Dalin Rifat is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Mycobacterium research and diagnosis (11 papers) and Bacterial Genetics and Biotechnology (4 papers). Dalin Rifat collaborates with scholars based in United States, Australia and United Kingdom. Dalin Rifat's co-authors include Petros C. Karakousis, William R. Bishai, Lindsay W. Black, Eric L. Nuermberger, Yu-Min Chuang, Joel S. Bader, Thomas R. Ioerger, Nirmalya Bandyopadhyay, Barry N. Kreiswirth and Liang Chen and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Journal of Bacteriology.

In The Last Decade

Dalin Rifat

15 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dalin Rifat United States 14 424 367 281 132 98 15 640
Pratik Datta United States 12 369 0.9× 315 0.9× 346 1.2× 104 0.8× 115 1.2× 18 689
John L. Dahl United States 16 533 1.3× 559 1.5× 412 1.5× 148 1.1× 144 1.5× 26 964
Lee G. Klinkenberg United States 11 401 0.9× 310 0.8× 300 1.1× 30 0.2× 97 1.0× 13 632
Shaun B. Walters Australia 10 491 1.2× 388 1.1× 276 1.0× 37 0.3× 74 0.8× 14 667
Sahadevan Raman United States 11 477 1.1× 397 1.1× 346 1.2× 74 0.6× 106 1.1× 14 707
Eileen Pagán-Ramos United States 9 264 0.6× 244 0.7× 215 0.8× 35 0.3× 84 0.9× 12 562
Xiaoling Puyang United States 10 293 0.7× 283 0.8× 282 1.0× 44 0.3× 85 0.9× 15 572
Angelina Iniguez United States 10 247 0.6× 147 0.4× 266 0.9× 38 0.3× 49 0.5× 12 558
Ashley M. Sherrid United States 8 260 0.6× 238 0.6× 224 0.8× 33 0.3× 71 0.7× 10 498
Samuel C. Woolwine United States 10 411 1.0× 362 1.0× 216 0.8× 34 0.3× 74 0.8× 10 580

Countries citing papers authored by Dalin Rifat

Since Specialization
Citations

This map shows the geographic impact of Dalin Rifat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dalin Rifat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dalin Rifat more than expected).

Fields of papers citing papers by Dalin Rifat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dalin Rifat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dalin Rifat. The network helps show where Dalin Rifat may publish in the future.

Co-authorship network of co-authors of Dalin Rifat

This figure shows the co-authorship network connecting the top 25 collaborators of Dalin Rifat. A scholar is included among the top collaborators of Dalin Rifat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dalin Rifat. Dalin Rifat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Kurepina, Natalia, et al.. (2022). CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on β-Lactam Susceptibility. Antimicrobial Agents and Chemotherapy. 66(4). e0009322–e0009322. 17 indexed citations
2.
Rifat, Dalin, Liang Chen, Barry N. Kreiswirth, & Eric L. Nuermberger. (2021). Genome-Wide Essentiality Analysis of Mycobacterium abscessus by Saturated Transposon Mutagenesis and Deep Sequencing. mBio. 12(3). e0104921–e0104921. 38 indexed citations
3.
Rifat, Dalin, Si-Yang Li, Thomas R. Ioerger, et al.. (2020). Mutations in fbiD ( Rv2983 ) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 65(1). 56 indexed citations
4.
Rifat, Dalin, et al.. (2018). Gene Enrichment Analysis Reveals Major Regulators of Mycobacterium tuberculosis Gene Expression in Two Models of Antibiotic Tolerance. Frontiers in Microbiology. 9. 610–610. 10 indexed citations
5.
Campodónico, Victoria L., Dalin Rifat, Yu-Min Chuang, Thomas R. Ioerger, & Petros C. Karakousis. (2018). Altered Mycobacterium tuberculosis Cell Wall Metabolism and Physiology Associated With RpoB Mutation H526D. Frontiers in Microbiology. 9. 494–494. 26 indexed citations
6.
Rifat, Dalin, Brendan Prideaux, Radojka M. Savić, et al.. (2018). Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data. Science Translational Medicine. 10(435). 40 indexed citations
7.
Rifat, Dalin, Victoria L. Campodónico, Jing Tao, et al.. (2017). In Vitro and in Vivo Fitness Costs Associated with Mycobacterium Tuberculosis RpoB Mutation H526D. Future Microbiology. 12(9). 753–765. 20 indexed citations
8.
Chuang, Yu-Min, Nirmalya Bandyopadhyay, Dalin Rifat, et al.. (2015). Deficiency of the Novel Exopolyphosphatase Rv1026/PPX2 Leads to Metabolic Downshift and Altered Cell Wall Permeability in Mycobacterium tuberculosis. mBio. 6(2). 1253–1253. 70 indexed citations
9.
Rifat, Dalin, Deborah Belchis, & Petros C. Karakousis. (2014). senX3-independent contribution of regX3 to Mycobacterium tuberculosis virulence. BMC Microbiology. 14(1). 265–265. 23 indexed citations
10.
Rifat, Dalin & Petros C. Karakousis. (2014). Differential regulation of the two-component regulatory system senX3-regX3 in Mycobacterium tuberculosis. Microbiology. 160(6). 1125–1133. 16 indexed citations
11.
Chia, Bing Shao, Dalin Rifat, Edith Torres-Chavolla, et al.. (2012). Use of Multiplex Allele-Specific Polymerase Chain Reaction (MAS-PCR) to Detect Multidrug-Resistant Tuberculosis in Panama. PLoS ONE. 7(7). e40456–e40456. 23 indexed citations
12.
Bisson, Gregory P., Carolina Mehaffy, Corey D. Broeckling, et al.. (2012). Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis. Journal of Bacteriology. 194(23). 6441–6452. 73 indexed citations
13.
Rifat, Dalin, William R. Bishai, & Petros C. Karakousis. (2009). Phosphate Depletion: A Novel Trigger forMycobacterium tuberculosisPersistence. The Journal of Infectious Diseases. 200(7). 1126–1135. 121 indexed citations
14.
Rifat, Dalin, Nathan T. Wright, Kristen M. Varney, David J. Weber, & Lindsay W. Black. (2007). Restriction Endonuclease Inhibitor IPI* of Bacteriophage T4: A Novel Structure for a Dedicated Target. Journal of Molecular Biology. 375(3). 720–734. 55 indexed citations
15.
Rifat, Dalin, et al.. (2006). Exclusion of Glucosyl-Hydroxymethylcytosine DNA Containing Bacteriophages Is Overcome by the Injected Protein Inhibitor IPI*. Journal of Molecular Biology. 366(3). 779–789. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026